THERAPEUTIC CLASS

Malignant pleural effusion: from bench to bedside

---

Malignant pleural effusion (MPE) is a common but serious condition that is related with poor quality of life, morbidity and mortality. Its incidence and associated healthcare costs are rising and its management remains palliative, with median survival ranging from 3 to 12 months. During the last decade there has been significant progress in unravelling the pathophysiology of MPE, as well as its diagnostics, imaging, and management. Nowadays, formerly bed-ridden patients are genotyped, phenotyped, and treated on an ambulatory basis.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Oncology
Fonkopac
Epirubicin
Carboplatin

Specific Detail Info

Eur Respir Rev 2016; 25: 000–000.

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment